Skip to main content

Advertisement

Log in

Effects of zinc porphyrin and zinc phthalocyanine derivatives in photodynamic anticancer therapy under different partial pressures of oxygen in vitro

  • PRECLINICAL STUDIES
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Summary

Photodynamic therapy (PDT) is gradually becoming an alternative method in the treatment of several diseases. Here, we investigated the role of oxygen in photodynamically treated cervical cancer cells (HeLa). The effect of PDT on HeLa cells was assessed by exposing cultured cells to disulphonated zinc phthalocyanine (ZnPcS2) and tetrasulphonated zinc tetraphenylporphyrin (ZnTPPS4). Fluorescence microscopy revealed their different localizations within the cells. ZnTPPS4 seems to be mostly limited to the cytosol and lysosomes, whereas ZnPcS2 is most likely predominantly attached to membrane structures, including plasmalemma and the mitochondrial membrane. Phototoxicity assays of PDT-treated cells carried out under different partial pressures of oxygen showed dose-dependent responses. Interestingly, ZnPcS2 was also photodynamically effective at a minimal level of oxygen, under a nitrogen atmosphere. On the other hand, hyperbaric oxygenation did not lead to a higher PDT efficiency of either photosensitizer. Although both photosensitizers can induce a significant drop in mitochondrial membrane potential, ZnPcS2 has a markedly higher effect on mitochondrial respiration that was completely blocked after two short light cycles. In conclusion, our observations suggest that PDT can be effective even in hypoxic conditions if a suitable sensitizer is chosen, such as ZnPcS2, which can inhibit mitochondrial respiration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Kwiatkowski S, Knap B, Przystupski D, Saczko J, Kędzierska E, Knap-Czop K, Kotlińska J, Michel O, Kotowski K, Kulbacka J (2018) Photodynamic therapy - mechanisms, photosensitizers and combinations. Biomed Pharmacother 106:1098–1107

    Article  CAS  Google Scholar 

  2. van den Bergh H (1986) Light and porphyrins in cancer therapy. Chem Br 22:430–439

    Google Scholar 

  3. Castano AP, Demidova TN, Hamblin MR (2005) Mechanisms in photodynamic therapy: part two - cellular signaling, cell metabolism and modes of cell death. Photodiagn Photodyn Ther 2:1–23

    Article  CAS  Google Scholar 

  4. Robertson CA, Evans DH, Abrahamse H (2009) Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B Biol 96:1–8

    Article  CAS  Google Scholar 

  5. Luksiene Z (2003) Photodynamic therapy: mechanism of action and ways to improve the efficiency of treatment. Med (Kaunas) 39:1137–1150

    Google Scholar 

  6. Juzeniene A, Moan J (2007) The history of PDT in Norway. Photodiagn Photodyn Ther 4:3–11

    Article  CAS  Google Scholar 

  7. Nowak-Stepniowska A, Pergoł P, Padzik-Graczyk A (2013) Photodynamic method of cancer diagnosis and therapy - mechanisms and applications. Postepy Biochem 59:53–63

    PubMed  Google Scholar 

  8. Fischer SM, Jain KK, Braun E, Lehr S (1988) Handbook of hyperbaric oxygen therapy. Springer, Berlin

    Book  Google Scholar 

  9. Neves A, Abrantes A, Pires A, Teixo R, Botelho MF (2016) Hyperbaric oxygen therapy combined with photodynamic therapy as a new therapeutic approach against retinoblastoma. Eur J Cancer 61:144

    Article  Google Scholar 

  10. Bajgar R, Kolarova H, Bolek L, Binder S, Pizova K, Hanakova A (2014) High oxygen partial pressure increases photodynamic effect on HeLa cell lines in the presence of chloraluminium phthalocyanine. Anticancer Res 34:4095–4099

    CAS  PubMed  Google Scholar 

  11. Jirsa M Jr, Pouckova P, Dolezal J, Pospisil J, Jirsa M (1991) Hyperbaric oxygen and photodynamic therapy in tumor bearing nude mice. Eur J Cancer 27:109

    Article  Google Scholar 

  12. Fuchs J, Thiele J (1998) The role of oxygen in cutaneous photodynamic therapy. Free Radic Biol Med 24:835–847

    Article  CAS  Google Scholar 

  13. Moan J, Berg K (1991) The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol 53:549–553

    Article  CAS  Google Scholar 

  14. Castano AP, Demidova TN, Hamblin MR (2004) Mechanisms in photo-dynamic therapy: part one: photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther 1:279–293

    Article  CAS  Google Scholar 

  15. Krestyn E, Kolarova H, Bajgar R, Tomankova K (2010) Photodynamic properties of ZnTPPS4, ClAlPcS2 and ALA in human melanoma G361 cells. Toxicol in Vitro 24:286–291

    Article  CAS  Google Scholar 

  16. Wilson BC, Patterson MS (2008) The physics, biophysics and technology of photodynamic therapy. Phys Med Biol 53:61–109

    Article  Google Scholar 

  17. Kriska T, Korytowski W, Girotti AW (2002) Hyperresistance to photosensitized lipid peroxidation and apoptotic killing in 5-aminolevulinate-treated tumor cells overexpressing mitochondrial GPX4. Free Radic Biol Med 33:1389–1402

    Article  CAS  Google Scholar 

  18. Kessel D (2002) Relocalization of cationic porphyrins during photodynamic therapy. Photochem Photobiol Sci 1:837–840

    Article  CAS  Google Scholar 

  19. Furre IE, Shahzidi S, Luksiene Z, Moller MT, Borgen E, Morgan J, Tkacz-Stachowska K, Nesland JM, Peng Q (2005) Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells. Cancer Res 65:11051–11060

    Article  CAS  Google Scholar 

  20. Ichinose S, Usuda J, Hirata T, Inoue T, Ohtani K, Maehara S, Kubota M, Imai K, Tsunoda Y, Kuroiwa Y, Yamada K, Tsutsui H, Furukawa K, Okunaka T, Oleinick NL, Kato H (2006) Lysosomal cathepsin initiates apoptosis, which is regulated by photodamage to Bcl-2 at mitochondria in photodynamic therapy using a novel photosensitizer, ATX-s10 (Na). Int J Oncol 29:349–355

    CAS  PubMed  Google Scholar 

  21. Ji Z, Yang G, Vasovic V, Cunderlikova B, Suo Z, Nesland JM, Peng Q (2006) Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines. J Photochem Photobiol B Biol 84:213–220

    Article  CAS  Google Scholar 

  22. Kessel D, Castelli M (2001) Evidence that bcl-2 is the target of three photosensitizers that induce a rapid apoptotic response. Photochem Photobiol 74:318–322

    Article  CAS  Google Scholar 

  23. Lam M, Oleinick NL, Nieminen AL (2001) Photodynamic therapy-induced apoptosis in epidermoid carcinoma cells. Reactive oxygen species and mitochondrial inner membrane permeabilization. J Biol Chem 276:47379–47386

    Article  CAS  Google Scholar 

  24. Usuda J, Chiu SM, Murphy ES, Lam M, Nieminen AL, Oleinick NL (2003) Domain-dependent photodamage to Bcl-2. A membrane anchorage region is needed to form the target of phthalocyanine photo-sensitization. J Biol Chem 278:2021–2029

    Article  CAS  Google Scholar 

  25. Xue LY, Chiu SM, Fiebig A, Andrews DW, Oleinick NL (2003) Photodamage to multiple Bcl-xL isoforms by photodynamic therapy with the phthalocyanine photosensitizer pc 4. Oncogene 22:9197–9204

    Article  CAS  Google Scholar 

  26. Wood SR, Holroyd JA, Brown SB (1997) The subcellular localization of Zn (II) phthalocyanines and their redistribution on exposure to light. J Photochem Photobiol B 65:397–402

    Article  CAS  Google Scholar 

  27. Fabrics C, Valduga G, Miotto G, Borsetto L, Jori G, Garbisa S, Reddi E (2001) Photosensitization witn zinc(II) phthalocyanine as switch in the decision between apoptosis and necrosis. Cancer Res 61:7495–7502

    Google Scholar 

  28. Tynga IM, Houreld NN, Abrahamse H (2013) The primary subcellular localization of zinc phthalocyanine and its cellular impact on viability, proliferation and structure of breast cancer cells (MCF-7). J Photochem Photobiol B 120:171–176

    Article  CAS  Google Scholar 

  29. Oniszczuk A, Wojtunik-Kulesza KA, Oniszczuk T, Kasprzak K (2016) The potential of photodynamic therapy (PDT)-experimental investigations and clinical use. Biomed Pharmacother 83:912–929

    Article  CAS  Google Scholar 

  30. Lee SK, Forbes IJ, Betts WH (1984) Oxygen dependency of photocytotoxicity with hemtoporphyrin derivative. Photochem Photobiol 39:631–634

    Article  Google Scholar 

  31. Moan J, Sommer S (1985) Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK-3025 cells. Cancer Res 45:1608–1610

    CAS  PubMed  Google Scholar 

  32. Henderson BW, Fingar VH (1987) Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res 47:3110–3114

    CAS  PubMed  Google Scholar 

  33. Chapman JD, Stobbe CC, Arnfield MR (1991) Oxygen dependency of tumor cell killing in vitro by light activated Photofrin II. Radiat Res 126:73–79

    Article  CAS  Google Scholar 

  34. Daruwalla J, Christophi C (2006) Hyperbaric oxygen therapy for malignancy: a review. World J Surg 30:2112–2131

    Article  Google Scholar 

  35. Ricci JE (2003) Caspase-mediated loss of mitochondrial function and generation ofreactive oxygen species during apoptosis. J Cell Biol 160:65–75

    Article  CAS  Google Scholar 

  36. Cosentino K, García-Sáez AJ (2014) Mitochondrial alterations in apoptosis. Chem Phys Lipids 181:62–75

    Article  CAS  Google Scholar 

  37. Zorova LD, Popkov VA, Plotnikov EY, Silachev DN, Pevzner IB, Jankauskas SS, Babenko VA, Zorov SD, Balakireva AV, Juhaszova M, Sollott SJ, Zorov DB (2018) Mitochondrial membrane potential. Anal Biochem 552:50–59

    Article  CAS  Google Scholar 

  38. Ly JD, Grubb DR, Lawen A (2003) The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 8:115–128

    Article  CAS  Google Scholar 

  39. Izyumov DS, Avetisyan AV, Pletjushkina OY, Sakharov DV, Wirtz KW, Chernyak BV, Skulachev VP (2004) “Wages of fear”: transient threefold decrease in intracellular ATP level imposes apoptosis. Biochim Biophys Acta 1658:141–147

    Article  CAS  Google Scholar 

  40. Hodgkinson N, Kruger CA, Mokwena M, Abrahamse H (2017) Cervical cancer cells (HeLa) response to photodynamic therapy using a zinc phthalocyanine photosensitizer. Photochem Photobiol B 177:32–38

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank American Journal Experts (http://aje.com) for proofreading our manuscript.

Funding

This work was supported by the grants from the Ministry of Education, Youth and Sports of the Czech Republic LO1304, LM2015062, European Regional Development Fund CZ.02.1.01/0.0/0.0/16_019/0000868.

Author information

Authors and Affiliations

Authors

Contributions

M.P. performed most of the experiments and analyzed the data. J.R. developed the small hyperbaric chamber and assisted in experiments carried out under hyperbaric conditions. A.Z. and M.M. performed the measurements of cellular respiration and analyzed the acquired data. J.M. synthetized the photosensitizers. R.B. and H.K. designed the study, interpreted the results and wrote the manuscript. All authors read and approved the final version of the manuscript.

Corresponding author

Correspondence to Robert Bajgar.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study, formal consent is not required.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pola, M., Kolarova, H., Ruzicka, J. et al. Effects of zinc porphyrin and zinc phthalocyanine derivatives in photodynamic anticancer therapy under different partial pressures of oxygen in vitro. Invest New Drugs 39, 89–97 (2021). https://doi.org/10.1007/s10637-020-00990-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10637-020-00990-7

Keywords

Navigation